Assembly Biosciences, Inc. (ASMB)
USD 14.18
(23.95%)
USD 14.18
(23.95%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -41.73 Million USD | 1447.99% |
| 2022 | -498 Thousand USD | -108.6% |
| 2021 | 5.78 Million USD | -92.67% |
| 2020 | 79 Million USD | 397.58% |
| 2019 | 15.87 Million USD | 127.41% |
| 2018 | -57.93 Million USD | -64.56% |
| 2017 | -35.2 Million USD | -43770.17% |
| 2016 | -80.25 Thousand USD | -23.48% |
| 2015 | -64.98 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 8.5 Million USD | 47.77% |
| 2024 Q1 | 5.75 Million USD | -18.73% |
| 2023 Q2 | -126 Thousand USD | -1.61% |
| 2023 Q1 | -124 Thousand USD | 0.0% |
| 2023 FY | 6.71 Million USD | 1447.99% |
| 2023 Q3 | -116 Thousand USD | 7.94% |
| 2023 Q4 | 7.07 Million USD | 6202.59% |
| 2022 Q3 | -134 Thousand USD | -11.67% |
| 2022 Q4 | -124 Thousand USD | 7.46% |
| 2022 Q1 | -120 Thousand USD | 0.0% |
| 2022 Q2 | -120 Thousand USD | 0.0% |
| 2022 FY | -498 Thousand USD | -108.6% |
| 2021 Q2 | -120 Thousand USD | -12.15% |
| 2021 FY | 5.78 Million USD | -92.67% |
| 2021 Q1 | -107 Thousand USD | 99.6% |
| 2021 Q3 | -12.22 Million USD | -10083.33% |
| 2021 Q4 | -120 Thousand USD | 99.02% |
| 2020 FY | 79 Million USD | 397.58% |
| 2020 Q4 | -26.98 Million USD | -451.84% |
| 2020 Q3 | 7.67 Million USD | -52.21% |
| 2020 Q2 | 16.04 Million USD | 184.62% |
| 2020 Q1 | -18.96 Million USD | -8.89% |
| 2019 FY | 15.87 Million USD | 127.41% |
| 2019 Q1 | -18.81 Million USD | -7.44% |
| 2019 Q2 | -15.62 Million USD | 17.0% |
| 2019 Q4 | -17.41 Million USD | 0.5% |
| 2019 Q3 | -17.5 Million USD | -12.07% |
| 2018 Q4 | -17.51 Million USD | -18.16% |
| 2018 Q1 | -10.97 Million USD | -50.74% |
| 2018 Q2 | -14.62 Million USD | -33.22% |
| 2018 FY | -57.93 Million USD | -64.56% |
| 2018 Q3 | -14.82 Million USD | -1.37% |
| 2017 Q4 | -7.28 Million USD | 11.95% |
| 2017 Q3 | -8.26 Million USD | 15.32% |
| 2017 Q2 | -9.76 Million USD | 1.25% |
| 2017 FY | -35.2 Million USD | -43770.17% |
| 2017 Q1 | -9.88 Million USD | -14.69% |
| 2016 Q2 | -7.51 Million USD | 7.38% |
| 2016 FY | -80.25 Thousand USD | -23.48% |
| 2016 Q3 | -8.83 Million USD | -17.48% |
| 2016 Q1 | -8.11 Million USD | 0.0% |
| 2016 Q4 | -8.62 Million USD | 2.39% |
| 2015 FY | -64.98 Thousand USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 100.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q4 | -16.39 Billion USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -42927.835% |
| Psyence Biomedical Ltd. | -240.00 USD | -17390316.667% |
| XOMA Corporation | 3.86 Million USD | 1180.989% |
| Mesoblast Limited | -9.81 Million USD | -325.237% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 130.855% |
| Aptorum Group Limited | -1.11 Million USD | -3644.276% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -928420.578% |
| HilleVax, Inc. | -2.15 Million USD | -1835.853% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -488.011% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -33.911% |
| Precision BioSciences, Inc. | 40.47 Million USD | 203.126% |
| Dyadic International, Inc. | 922.95 Thousand USD | 4622.096% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -28292.517% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 60.671% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 298.172% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 9943.632% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 200.848% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 144.062% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -380.454% |
| IGM Biosciences, Inc. | -211.66 Million USD | 80.281% |
| Opthea Limited | 21.72 Thousand USD | 192259.3% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 10482.338% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 1814.045% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 1478.824% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 134.853% |
| NextCure, Inc. | -3.68 Million USD | -1032.926% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -212.453% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -3363.996% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 308.144% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 126.963% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 57.505% |
| Senti Biosciences, Inc. | -2.68 Million USD | -1455.609% |
| Apollomics, Inc. | 127 Thousand USD | 32963.78% |
| PureTech Health plc | -1.6 Million USD | -2503.681% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -44.08% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 5304.115% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 62.225% |
| ChromaDex Corporation | 50.78 Million USD | 182.192% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 134.644% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 7.916% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -566.725% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 57.482% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 34880.833% |
| Fortress Biotech, Inc. | 57.85 Million USD | 172.143% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 3.971% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -181365.217% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 32205.385% |
| Celcuity Inc. | -142.77 Thousand USD | -29133.323% |
| ContextLogic Inc. | 59 Million USD | 170.741% |
| GH Research PLC | -315 Thousand USD | -13149.841% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 351.777% |
| Cassava Sciences, Inc. | -89.42 Million USD | 53.326% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 10829.306% |
| ImmuCell Corporation | 4.39 Million USD | 1049.37% |
| Amarin Corporation plc | 165.54 Million USD | 125.212% |
| TG Therapeutics, Inc. | 219.1 Million USD | 119.049% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -1991.032% |
| Acelyrin, Inc. | -115 Thousand USD | -36193.043% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Seer, Inc. | 7.02 Million USD | 693.952% |
| Novavax, Inc. | 639.93 Million USD | 106.522% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 8204.272% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 101.228% |
| AnaptysBio, Inc. | 14.78 Million USD | 382.369% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -7261.023% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -3220.366% |
| AbCellera Biologics Inc. | 38.02 Million USD | 209.762% |
| CorMedix Inc. | -205.56 Thousand USD | -20203.85% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 270.696% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -487.377% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.369% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -8695.162% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -401217.308% |
| Soligenix, Inc. | 97.31 Thousand USD | 42990.321% |
| Century Therapeutics, Inc. | -10.8 Million USD | -286.132% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 117.337% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -7976.889% |
| Kura Oncology, Inc. | -849 Thousand USD | -4816.019% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -1075.359% |
| Ardelyx, Inc. | 106.66 Million USD | 139.131% |
| Ainos, Inc. | -253.73 Thousand USD | -16349.181% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 37.803% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| Prothena Corporation plc | -129.2 Million USD | 67.696% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 142.142% |
| Autolus Therapeutics plc | -4.86 Million USD | -757.551% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 182.772% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -24743.452% |
| Celularity Inc. | 6.75 Million USD | 717.868% |
| Rallybio Corporation | -150 Thousand USD | -27724.667% |
| GRI Bio, Inc. | 10.84 Million USD | 484.992% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 1743.198% |
| Omeros Corporation | -69.77 Million USD | 40.187% |
| INmune Bio, Inc. | 155 Thousand USD | 27027.097% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 167.384% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -2670.846% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -6336.386% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -142473.615% |
| Humacyte, Inc. | -76.55 Million USD | 45.477% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -13234.505% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 144.184% |
| Immunocore Holdings plc | 248.39 Million USD | 116.803% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -175.147% |
| Verastem, Inc. | -62 Thousand USD | -67217.742% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -15891.188% |
| Histogen Inc. | 3.76 Million USD | 1207.376% |
| Surrozen, Inc. | -27.23 Million USD | -53.276% |
| Blueprint Medicines Corporation | 236.58 Million USD | 117.642% |
| Organovo Holdings, Inc. | -5.38 Million USD | -674.485% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| IO Biotech, Inc. | -756 Thousand USD | -5420.767% |
| MEI Pharma, Inc. | 49.32 Million USD | 184.613% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 788.0% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -62072.469% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -2826.858% |
| Summit Therapeutics Inc. | -2.05 Million USD | -1935.951% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -769.883% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 243.648% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 28726.2% |
| Turnstone Biologics Corp. | 16.5 Million USD | 352.86% |
| Pulmatrix, Inc. | -8.22 Million USD | -407.749% |
| Synaptogenix, Inc. | -6347.00 USD | -657486.261% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -81737.255% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 125.865% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -10360.401% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 89.534% |
| Cytokinetics, Incorporated | -322.59 Million USD | 87.062% |
| Exelixis, Inc. | 1.75 Billion USD | 102.375% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 62.788% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 112.345% |
| Evogene Ltd. | 1.39 Million USD | 3083.345% |
| Replimune Group, Inc. | -2.65 Million USD | -1472.015% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -72706.405% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -3666.877% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -35123.772% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| BioLineRx Ltd. | 1.1 Million USD | 3866.877% |
| Avid Bioservices, Inc. | 7.31 Million USD | 670.333% |
| Insmed Incorporated | 239.63 Million USD | 117.417% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 8514.718% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -2904.824% |
| Sagimet Biosciences Inc. | 2 Million USD | 2186.85% |
| MediWound Ltd. | 3.57 Million USD | 1266.49% |
| MiMedx Group, Inc. | 266.84 Million USD | 115.641% |
| OmniAb, Inc. | 14.66 Million USD | 384.564% |
| Alector, Inc. | -95.05 Million USD | 56.091% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 133.225% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 104.785% |
| Mereo BioPharma Group plc | 7.42 Million USD | 662.039% |
| Zai Lab Limited | 170.9 Million USD | 124.421% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 150.975% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -347708.333% |
| Aura Biosciences, Inc. | -1.29 Million USD | -3122.934% |
| Immunic, Inc. | -111 Thousand USD | -37500.901% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -1595.937% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 363.258% |
| Veracyte, Inc. | 248.14 Million USD | 116.819% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 99.403% |
| FibroGen, Inc. | 128.9 Million USD | 132.378% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Allakos Inc. | -6.14 Million USD | -579.645% |
| scPharmaceuticals Inc. | 9.78 Million USD | 526.671% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 39.508% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 108.77% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -7400077.305% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -365757.293% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -257.739% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 111.745% |
| Precigen, Inc. | 106 Thousand USD | 39474.528% |
| Fortrea Holdings Inc. | 424 Million USD | 109.844% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 51.563% |
| Incyte Corporation | 3.44 Billion USD | 101.213% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -82156.602% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 382.121% |
| XBiotech Inc. | -1.74 Million USD | -2293.177% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 434.968% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -3666.877% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| CRISPR Therapeutics AG | 240.95 Million USD | 117.321% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -143820.69% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 10.187% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 44.744% |
| Agenus Inc. | 139.61 Million USD | 129.894% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -936.42% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 156.86% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 348.39% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 110.728% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 15.932% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 21535.688% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 112.773% |
| UroGen Pharma Ltd. | 73.35 Million USD | 156.9% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -268.576% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -56.353% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 773007.407% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -21983.069% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -62355.295% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 1130.289% |
| Chimerix, Inc. | 324 Thousand USD | 12981.79% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -7849.905% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -94353.245% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -18787.486% |
| Pluri Inc. | 322 Thousand USD | 13061.801% |
| Cue Biopharma, Inc. | -32.6 Million USD | -28.0% |
| MeiraGTx Holdings plc | 287 Thousand USD | 14642.509% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 7343.756% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -2107829.293% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 166.906% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -299.59% |
| CalciMedica, Inc. | -58 Thousand USD | -71860.345% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -1367.546% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -35.224% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -3467.265% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -365757.293% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 1603.719% |
| Nutriband Inc. | 862.1 Thousand USD | 4941.29% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -12139.589% |
| Vor Biopharma Inc. | -3.49 Million USD | -1095.218% |
| Roivant Sciences Ltd. | 109.23 Million USD | 138.208% |
| ProKidney Corp. | -3.16 Million USD | -1217.04% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 4.953% |
| Daré Bioscience, Inc. | 2.76 Million USD | 1607.011% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 708.677% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -2313.939% |
| Bicycle Therapeutics plc | -129.52 Million USD | 67.776% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 46.947% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -126375.758% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 89.557% |
| Atai Life Sciences N.V. | -5000.00 USD | -834640.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -34150.24% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -43376.042% |
| MediciNova, Inc. | 979.7 Thousand USD | 4360.16% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 50.501% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -44040.447% |
| GeoVax Labs, Inc. | -20.72 Million USD | -101.426% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 173.626% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 117.068% |
| Biomea Fusion, Inc. | -4.2 Million USD | -893.502% |
| RenovoRx, Inc. | - USD | Infinity% |
| Erasca, Inc. | -3.73 Million USD | -1018.355% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -13363.548% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -834640.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 45.351% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 119.527% |
| bluebird bio, Inc. | -4.03 Million USD | -935.658% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -4335.388% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 4236.472% |
| Imunon, Inc. | -720 Thousand USD | -5696.765% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 102.192% |
| BioAtla, Inc. | -103.73 Million USD | 59.764% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 82.811% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -13320.257% |
| DBV Technologies S.A. | 15.72 Million USD | 365.367% |
| Fortress Biotech, Inc. | 57.85 Million USD | 172.143% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 76.993% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 40.448% |
| aTyr Pharma, Inc. | -2.38 Million USD | -1647.781% |
| Viridian Therapeutics, Inc. | -1 Million USD | -4040.575% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 321053946.154% |
| Galecto, Inc. | -830 Thousand USD | -4928.554% |
| Akari Therapeutics, Plc | -4000.00 USD | -1043325.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 106.553% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 3829.848% |
| Entera Bio Ltd. | -56 Thousand USD | -74430.357% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 131.196% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -7209.457% |
| Xencor, Inc. | -85.26 Million USD | 51.047% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 1721.484% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -6.085% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -4068.548% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 123.468% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 21535.688% |
| Portage Biotech Inc. | -54 Thousand USD | -77190.741% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -44040.447% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -10970.822% |
| OncoCyte Corporation | 413 Thousand USD | 10205.811% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -18800350.45% |
| Purple Biotech Ltd. | -196 Thousand USD | -21194.388% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 565.399% |
| Onconetix, Inc. | -1.12 Million USD | -3602.83% |
| MacroGenics, Inc. | 50.52 Million USD | 182.603% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -278072.487% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -6148.054% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 319.172% |
| Prime Medicine, Inc. | -147.9 Million USD | 71.781% |
| Aditxt, Inc. | -111.66 Thousand USD | -37278.649% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -555936.642% |
| Savara Inc. | -44.26 Million USD | 5.705% |
| Curis, Inc. | 9.81 Million USD | 525.41% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -33346.325% |
| Adagene Inc. | 18.11 Million USD | 330.445% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -18205.702% |
| BeiGene, Ltd. | 2.07 Billion USD | 102.008% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 6953.366% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -29025.407% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 129.769% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -147809.136% |
| SciSparc Ltd. | 2.19 Million USD | 2000.592% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -147809.136% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -4461.421% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -166521.422% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -134613.705% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 621.322% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 176.415% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -7686.754% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 102.75% |
| ADMA Biologics, Inc. | 88.21 Million USD | 147.311% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 138.022% |
| Clene Inc. | 533 Thousand USD | 7930.582% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 62.442% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -1063.239% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -4261.233% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 2199.447% |
| Adicet Bio, Inc. | -6.09 Million USD | -584.438% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 183.801% |
| Absci Corporation | -41.84 Million USD | 0.268% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 8652.664% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 126.443% |
| Surrozen, Inc. | -27.23 Million USD | -53.276% |
| Generation Bio Co. | -73.91 Million USD | 43.531% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 46.214% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -9450.801% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 10.893% |
| Invivyd, Inc. | -2.02 Million USD | -1958.037% |
| Cingulate Inc. | -582.91 Thousand USD | -7060.012% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 86.127% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -40249.775% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -551247.424% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 143.31% |
| Jaguar Health, Inc. | 7.72 Million USD | 640.355% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 142.464% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 630.263% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -4637.457% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 106.131% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 273.117% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -21378.931% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Kronos Bio, Inc. | 1.37 Million USD | 3142.055% |
| Innoviva, Inc. | 261.06 Million USD | 115.987% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 22.228% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 243.283% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -4892.464% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 150.035% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 57186.388% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 178.509% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 75.901% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -11723.513% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -134535.484% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -111.874% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -4124.393% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -73977.953% |
| AlloVir, Inc. | -398 Thousand USD | -10386.683% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -3944.283% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 113.306% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -14193.493% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -6185.693% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 1140.045% |
| ImmunityBio, Inc. | -17.89 Million USD | -133.298% |
| Korro Bio, Inc. | -3.63 Million USD | -1049.78% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 56.95% |
| Kineta, Inc. | 5.43 Million USD | 868.213% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -23771.13% |
| BioVie Inc. | -229.37 Thousand USD | -18095.809% |
| Codexis, Inc. | 57.33 Million USD | 172.796% |
| Celularity Inc. | 6.75 Million USD | 717.868% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -11059.626% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 82600.494% |
| Kodiak Sciences Inc. | -25.94 Million USD | -60.855% |
| Cibus, Inc. | 1.42 Million USD | 3035.091% |
| Annexon, Inc. | -3.26 Million USD | -1177.533% |
| Moderna, Inc. | 2.15 Billion USD | 101.937% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 105.361% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -1941.928% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 6621.406% |
| Immix Biopharma, Inc. | -5468.00 USD | -763195.538% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 124.132% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -570.797% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 140.094% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -2096.684% |
| Alkermes plc | 1.37 Billion USD | 103.036% |
| Arcellx, Inc. | 108.27 Million USD | 138.546% |
| Moolec Science SA | -143.3 Thousand USD | -29024.594% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -28.941% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 1369.76% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 152.696% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -97.319% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 40.452% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -2108.307% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -1155409.413% |
| Humacyte, Inc. | -76.55 Million USD | 45.477% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 1.373% |
| Geron Corporation | -123.5 Million USD | 66.206% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 1053.335% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Royalty Pharma plc | 1.79 Billion USD | 102.327% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 18137.434% |
| Notable Labs, Ltd. | 113 Thousand USD | 37035.398% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 62.539% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -4297.192% |
| IN8bio, Inc. | -2.5 Million USD | -1568.812% |
| 89bio, Inc. | -273 Thousand USD | -15188.278% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -139023.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 2341.515% |
| Acasti Pharma Inc. | -11 Thousand USD | -379327.273% |
| Genelux Corporation | -848 Thousand USD | -4821.816% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -33832.52% |
| Liquidia Corporation | 14.6 Million USD | 385.87% |
| Mustang Bio, Inc. | -2.22 Million USD | -1775.82% |
| Immunovant, Inc. | -231 Thousand USD | -17967.965% |
| Vericel Corporation | 135.57 Million USD | 130.785% |
| Quantum-Si incorporated | 488 Thousand USD | 8652.664% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 24.878% |
| XOMA Corporation | 3.86 Million USD | 1180.989% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -108.31% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -20297.621% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -6336.386% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -3786.127% |
| Vaxcyte, Inc. | -75 Million USD | 44.351% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 75.084% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -10854.593% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -89.826% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 161.264% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -2031.614% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -4898.443% |
| PepGen Inc. | -1.18 Million USD | -3425.084% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -32763.78% |
| United Therapeutics Corporation | 2.07 Billion USD | 102.016% |
| Solid Biosciences Inc. | -76.56 Million USD | 45.487% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -50439.457% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Immuneering Corporation | -764.13 Thousand USD | -5361.972% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 63085.935% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -958.764% |
| Belite Bio, Inc | -399 Thousand USD | -10360.401% |
| Pharming Group N.V. | 220.1 Million USD | 118.962% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Bionomics Limited | -434.44 Thousand USD | -9506.881% |
| Pyxis Oncology, Inc. | -2 Million USD | -1986.85% |
| uniQure N.V. | 2.21 Million USD | 1984.289% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -50798.78% |
| GeoVax Labs, Inc. | -20.72 Million USD | -101.426% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 54.668% |
| Altimmune, Inc. | -65.37 Million USD | 36.156% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -3786.127% |
| Peak Bio, Inc. | 367.76 Thousand USD | 11448.7% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -9450.801% |
| Benitec Biopharma Inc. | 108 Thousand USD | 38745.37% |
| Zura Bio Limited | - USD | Infinity% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 111.529% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -415152.214% |
| Compugen Ltd. | 31.45 Million USD | 232.688% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 3778.63% |
| argenx SE | 1.1 Billion USD | 103.765% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 270.244% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -82.282% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -53408.974% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -3369.41% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -7819.734% |
| PolyPid Ltd. | -1.82 Million USD | -2190.724% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -34973.109% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -773.707% |
| Forte Biosciences, Inc. | -9000.00 USD | -463644.444% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 1789.073% |
| Instil Bio, Inc. | -4.75 Million USD | -777.565% |
| Elevation Oncology, Inc. | -39 Thousand USD | -106917.949% |
| Immunome, Inc. | -8.9 Million USD | -368.587% |
| Verona Pharma plc | -679.62 Thousand USD | -6041.19% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -10128.905% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -23749.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | -1649.979% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -1633.984% |
| Design Therapeutics, Inc. | -537 Thousand USD | -7672.253% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -9674.473% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 2044.874% |
| Achilles Therapeutics plc | -4.73 Million USD | -782.153% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 97162.791% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -4977.494% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -317098.662% |
| Beam Therapeutics Inc. | -59.67 Million USD | 30.056% |
| Moolec Science SA | -143.3 Thousand USD | -29024.594% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -834640.0% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 293.72% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -13952.862% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -336.306% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 396.428% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -1462.289% |
| Athira Pharma, Inc. | -969 Thousand USD | -4207.224% |
| HCW Biologics Inc. | -574.82 Thousand USD | -7160.831% |
| XOMA Corporation | 3.86 Million USD | 1180.989% |
| NeurAxis, Inc. | 2.15 Million USD | 2035.222% |
| Lumos Pharma, Inc. | 2 Million USD | 2179.571% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -23749.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -39395.623% |
| Nektar Therapeutics | 53.47 Million USD | 178.045% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -3369.41% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 231.834% |
| Arvinas, Inc. | 71.8 Million USD | 158.13% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Palisade Bio, Inc. | 246 Thousand USD | 17066.26% |
| Nutriband Inc. | 862.1 Thousand USD | 4941.29% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 8.367% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -126375.758% |
| Merus N.V. | -83.46 Million USD | 49.992% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 33.513% |
| Neurogene Inc. | -3.26 Million USD | -1179.491% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 129.954% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -75785.455% |
| CervoMed Inc. | -1.29 Million USD | -3126.355% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -1030.471% |
| Sesen Bio, Inc. | 40 Million USD | 204.343% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -12861.801% |
| Rezolute, Inc. | -36 Thousand USD | -115836.111% |
| Clene Inc. | 533 Thousand USD | 7930.582% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -3250445.171% |
| BeyondSpring Inc. | 1.75 Million USD | 2483.609% |
| Synlogic, Inc. | -1.92 Million USD | -2069.283% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -112702.703% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -559.144% |
| Peak Bio, Inc. | 367.76 Thousand USD | 11448.7% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -120.097% |
| Krystal Biotech, Inc. | 47.6 Million USD | 187.674% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 129.582% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 930.587% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -1511.953% |
| MannKind Corporation | 136.19 Million USD | 130.646% |
| Ikena Oncology, Inc. | -50.49 Million USD | 17.339% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 138.356% |
| Gossamer Bio, Inc. | -4.38 Million USD | -851.813% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -16462.302% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -834640.0% |
| Legend Biotech Corporation | 140.92 Million USD | 129.616% |
| Mural Oncology plc | -2.56 Million USD | -1525.906% |
| Disc Medicine, Inc. | -100 Thousand USD | -41637.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 301.103% |
| REGENXBIO Inc. | 53.02 Million USD | 178.706% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -679.118% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -21595.647% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -2309.758% |
| Vaxart, Inc. | -60.76 Million USD | 31.312% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -15782.868% |
| Cellectis S.A. | 18 Thousand USD | 231972.222% |
| Longeveron Inc. | 221 Thousand USD | 18985.52% |
| Repare Therapeutics Inc. | -80.07 Million USD | 47.874% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 103.819% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -3125.425% |
| Revolution Medicines, Inc. | -399.66 Million USD | 89.557% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -119148.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 85277.551% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 100.485% |
| Denali Therapeutics Inc. | -93.34 Million USD | 55.287% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -166521.422% |
| Veru Inc. | 7.56 Million USD | 651.644% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -27540.397% |
| Cingulate Inc. | -582.91 Thousand USD | -7060.012% |
| Passage Bio, Inc. | -3.72 Million USD | -1021.661% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -346437.695% |
| Exicure, Inc. | -1.42 Million USD | -2833.029% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -10797.389% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 1644.099% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -8041.025% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -27797.759% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 29.505% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 10774.425% |
| OmniAb, Inc. | 14.66 Million USD | 384.564% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 308.758% |
| Lipocine Inc. | -2.85 Million USD | -1364.036% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -2164.623% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -631.586% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -2670.846% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 155.416% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -64110.769% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 149.512% |
| Ocugen, Inc. | -33.53 Million USD | -24.451% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -1219.956% |
| Q32 Bio Inc. | 578 Thousand USD | 7320.934% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -15649.811% |
| Alumis Inc. Common Stock | -1.28 Million USD | -3150.545% |
| Equillium, Inc. | 35.95 Million USD | 216.072% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -2345.05% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 8436.08% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -1009503.29% |
| Dominari Holdings Inc. | 2.03 Million USD | 2146.935% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -22648.554% |
| vTv Therapeutics Inc. | -13.59 Million USD | -207.003% |
| Bio-Techne Corporation | 773.07 Million USD | 105.399% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 340.99% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 109.058% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -3470.317% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -74.049% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 456.818% |
| Nkarta, Inc. | -5.86 Million USD | -611.143% |
| BioCardia, Inc. | -7.24 Million USD | -475.762% |
| Iterum Therapeutics plc | -1.75 Million USD | -2284.971% |